We are live on ! Find out more
BCM

Bluefin Capital Management Portfolio holdings

AUM $156M
1-Year Est. Return 18.42%
This Fund
S&P 500
This Quarter Est. Return
+13.98%
1 Year Est. Return
+18.42%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.5B
AUM Growth
+$816M
Cap. Flow
+$933M
Cap. Flow %
61.97%
Top 10 Hldgs %
25.48%
Holding
816
New
310
Increased
153
Reduced
102
Closed
216

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$66.2M
2
MSFT icon
Microsoft
MSFT
+$48.6M
3
NVDA icon
NVIDIA
NVDA
+$21.3M
4
TIF
Tiffany & Co.
TIF
+$19.4M
5
GEN icon
Gen Digital
GEN
+$19.3M

Sector Composition

Rank Sector Weight
1 Technology 21.9%
2 Healthcare 11.35%
3 Financials 9.4%
4 Consumer Discretionary 8.24%
5 Communication Services 6.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UVXY icon
526
CALL
ProShares Ultra VIX Short-Term Futures ETF
UVXY
$228M
$12K ﹤0.01%
+10
New +$461K
WVE icon
527
CALL
Wave Life Sciences
WVE
$1.19B
$12K ﹤0.01%
+134,000
New +$3.29M
ICPT
528
PUT
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$12K ﹤0.01%
61,800
-26,800
-30% -$2.4M
PHGE.WS
529
DELISTED
BiomX Inc. Warrants to purchase one-half of a share of Common Stock
PHGE.WS
$12K ﹤0.01%
+25,000
New +$15.6K
AAL icon
530
PUT
American Airlines Group
AAL
$10.6B
$11K ﹤0.01%
11,600
+1,100
+10% +$31.4K
FXI icon
531
CALL
iShares China Large-Cap ETF
FXI
$4.29B
$11K ﹤0.01%
10,700
-116,000
-92% -$4.84M
PAAS icon
532
PUT
Pan American Silver
PAAS
$20.2B
$11K ﹤0.01%
+45,000
New +$834K
RARX
533
PUT
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$11K ﹤0.01%
+69,200
New +$3.06M
DERM
534
PUT
DELISTED
Dermira, Inc.
DERM
$11K ﹤0.01%
+50,000
New +$432K
ET icon
535
PUT
Energy Transfer Partners
ET
$71.2B
$9K ﹤0.01%
+10,000
New +$123K
AMTD
536
PUT
DELISTED
TD Ameritrade Holding Corp
AMTD
$9K ﹤0.01%
+227,600
New +$9.86M
CISN
537
CALL
DELISTED
Cision Ltd. Ordinary Share
CISN
$9K ﹤0.01%
184,300
-65,700
-26% -$628K
AXTA icon
538
PUT
Axalta
AXTA
$8.03B
$8K ﹤0.01%
+35,400
New +$1.04M
BMY icon
539
PUT
Bristol-Myers Squibb
BMY
$131B
$8K ﹤0.01%
184,400
+168,200
+1,038% +$9.63M
CI icon
540
PUT
Cigna
CI
$72.7B
$8K ﹤0.01%
100,200
-2,800
-3% -$513K
HYG icon
541
CALL
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.6B
$8K ﹤0.01%
+718,200
New +$62.5M
RVPHW
542
DELISTED
Reviva Pharmaceuticals Warrants
RVPHW
$8K ﹤0.01%
85,378
YPF icon
543
PUT
YPF Sociedad Anonima American Depositary Shares (Each representing ten (10) Class D shares of Capital Stock)
YPF
$19.5B
$8K ﹤0.01%
+118,300
New +$1.15M
FLG
544
PUT
Flagstar Bank National Association
FLG
$5.9B
$8K ﹤0.01%
15,500
+11,367
+275% +$420K
HPQ icon
545
CALL
HP
HPQ
$25.8B
$6K ﹤0.01%
+75,000
New +$1.42M
IQ icon
546
PUT
iQIYI
IQ
$1.24B
$6K ﹤0.01%
34,400
-51,800
-60% -$952K
IRM icon
547
CALL
Iron Mountain
IRM
$36.3B
$6K ﹤0.01%
257,200
ALACR
548
DELISTED
Alberton Acquisition Corp Rights
ALACR
$6K ﹤0.01%
25,000
AXSM icon
549
PUT
Axsome Therapeutics
AXSM
$10.8B
$5K ﹤0.01%
+60,400
New +$2.44M
CL icon
550
PUT
Colgate-Palmolive
CL
$74.1B
$5K ﹤0.01%
45,200
-306,300
-87% -$20.9M

Similar funds

Bluefin Capital Management's Q4 2019 Portfolio in Review

As of Q4 2019, Bluefin Capital Management held 816 positions worth $1.5B, up 118% from $689M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Bluefin Capital Management deployed $933M of net new capital in Q4 2019, opening 310 new positions and adding to 153 existing holdings. Its largest new stake was Tiffany & Co.: 164,299 shares worth $22M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 30% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was NXP Semiconductors, an estimated $165M trimmed.

  • Bluefin Capital Management's largest Q4 2019 buy was Tiffany & Co.: 164,299 shares worth $22M.
  • Bluefin Capital Management added most to Apple in Q4 2019, an estimated $66.2M increase.
  • Bluefin Capital Management's biggest Q4 2019 reduction was NXP Semiconductors, cutting an estimated $165M.
  • Bluefin Capital Management fully exited DTE Energy Company 2016 Corporate Units in Q4 2019, selling an estimated $20.9M.
  • Bluefin Capital Management's ten largest holdings make up 25% of its $1.5B portfolio in Q4 2019.
  • Bluefin Capital Management opened 310 new positions and closed 216 in Q4 2019.
  • Bluefin Capital Management's portfolio value rose 118% quarter-over-quarter to $1.5B.

Based on Bluefin Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.